Q2 2022 Matinas BioPharma Holdings Inc Earnings Call Transcript
Hello, and welcome to the Matinas BioPharma Second Quarter 2022 Results Conference Call. (Operator Instructions) As a reminder, this conference is being recorded. I would now like to turn the conference over to Peter Vozzo, Investor Relations Representative for Matinas BioPharma. You may begin.
Thank you, Kevin. Good morning, everyone, and thank you for joining the Matinas BioPharma second quarter 2022 results conference call. Earlier this morning, we issued a press release with our financial results along with business update. The release is available on the Matinas BioPharma website under the Investors section.
Speaking on today's call will be Jerry Jabbour, Chief Executive Officer; Dr. Terri Matkovits, Chief Development Officer; Keith Kucinski, Chief Financial Officer; and Dr. Raphael Mannino, Chief Scientific Officer. We also have Dr. Terry Ferguson, Chief Medical Officer; and Mr. Thomas Hoover, Chief Business Officer available to answer questions during our Q&A session.
At this time, I would
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
